BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26596835)

  • 1. NIK- and IKKβ-binding protein promotes colon cancer metastasis by activating the classical NF-κB pathway and MMPs.
    Qin M; Liu S; Li A; Xu C; Tan L; Huang J; Liu S
    Tumour Biol; 2016 May; 37(5):5979-90. PubMed ID: 26596835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of NIK and IKKβ-Binding Protein (NIBP) Reduces Colorectal Cancer Metastasis through Down-Regulation of the Canonical NF-κΒ Signaling Pathway and Suppression of MAPK Signaling Mediated through ERK and JNK.
    Qin M; Zhang J; Xu C; Peng P; Tan L; Liu S; Huang J
    PLoS One; 2017; 12(1):e0170595. PubMed ID: 28125661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NIBP impacts on the expression of E-cadherin, CD44 and vimentin in colon cancer via the NF-κB pathway.
    Xu CY; Qin MB; Tan L; Liu SQ; Huang JA
    Mol Med Rep; 2016 Jun; 13(6):5379-85. PubMed ID: 27109343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NIBP, a novel NIK and IKK(beta)-binding protein that enhances NF-(kappa)B activation.
    Hu WH; Pendergast JS; Mo XM; Brambilla R; Bracchi-Ricard V; Li F; Walters WM; Blits B; He L; Schaal SM; Bethea JR
    J Biol Chem; 2005 Aug; 280(32):29233-41. PubMed ID: 15951441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of Notch1, Jagged1, NF-κB and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.
    Zheng CG; Chen R; Xie JB; Liu CB; Jin Z; Jin C
    Cancer Biomark; 2015; 15(6):889-97. PubMed ID: 26406415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated NIBP/TRAPPC9 mediates tumorigenesis of cancer cells through NFκB signaling.
    Zhang Y; Liu S; Wang H; Yang W; Li F; Yang F; Yu D; Ramsey FV; Tuszyski GP; Hu W
    Oncotarget; 2015 Mar; 6(8):6160-78. PubMed ID: 25704885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NIK‑ and IKKβ‑binding protein contributes to gastric cancer chemoresistance by promoting epithelial‑mesenchymal transition through the NF‑κB signaling pathway.
    Fu ZH; Liu SQ; Qin MB; Huang JA; Xu CY; Wu WH; Zhu LY; Qin N; Lai MY
    Oncol Rep; 2018 Jun; 39(6):2721-2730. PubMed ID: 29620292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells.
    Shi W; Ye Z; Zhuang L; Li Y; Shuai W; Zuo Z; Mao X; Liu R; Wu J; Chen S; Huang W
    J Pathol; 2016 Nov; 240(3):352-365. PubMed ID: 27555280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression.
    Beshir AB; Ren G; Magpusao AN; Barone LM; Yeung KC; Fenteany G
    Cancer Lett; 2010 Dec; 299(2):137-49. PubMed ID: 20855151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer.
    Wang Y; Ren F; Wang Y; Feng Y; Wang D; Jia B; Qiu Y; Wang S; Yu J; Sung JJ; Xu J; Zeps N; Chang Z
    Carcinogenesis; 2014 May; 35(5):983-91. PubMed ID: 24302614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxycycline down-regulates matrix metalloproteinase expression and inhibits NF-κB signaling in LPS-induced PC3 cells.
    Ogut D; Reel B; Gonen Korkmaz C; Arun MZ; Cilaker Micili S; Ergur BU
    Folia Histochem Cytobiol; 2016; 54(4):171-180. PubMed ID: 27966209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
    Zhang J; Zhang DL; Jiao XL; Dong Q
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src Promotes Metastasis of Human Non-Small Cell Lung Cancer Cells through Fn14-Mediated NF-κB Signaling.
    Wang W; Liu F; Wang C; Wang C; Tang Y; Jiang Z
    Med Sci Monit; 2018 Mar; 24():1282-1294. PubMed ID: 29500337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROC1 promotes the malignant progression of bladder cancer by regulating p-IκBα/NF-κB signaling.
    Wu Q; Zhou X; Li P; Ding M; You S; Xu Z; Ye J; Chen X; Tan M; Wang J; Wang W; Qiu J
    J Exp Clin Cancer Res; 2021 May; 40(1):158. PubMed ID: 33962660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression.
    Ben-Shmuel A; Shvab A; Gavert N; Brabletz T; Ben-Ze'ev A
    Oncogene; 2013 Jul; 32(27):3220-30. PubMed ID: 22869145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.
    Huang M; Geng Y; Deng Q; Li R; Shao X; Zhang Z; Xu W; Wu Y; Ma Q
    Int J Oncol; 2018 Oct; 53(4):1481-1492. PubMed ID: 30066846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIPE3 protein promotes breast cancer metastasis through activating AKT and NF-κB signaling pathways.
    Lian K; Ma C; Hao C; Li Y; Zhang N; Chen YH; Liu S
    Oncotarget; 2017 Jul; 8(30):48889-48904. PubMed ID: 28388580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-κB Signaling Pathways.
    Ning L; Ma H; Jiang Z; Chen L; Li L; Chen Q; Qi H
    Integr Cancer Ther; 2016 Jun; 15(2):216-25. PubMed ID: 27125675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR4 promotes metastasis via ERK/NF-κB/MMP13 pathway and acts downstream of TNF-α in colorectal cancer.
    Ou B; Zhao J; Guan S; Feng H; Wangpu X; Zhu C; Zong Y; Ma J; Sun J; Shen X; Zheng M; Lu A
    Oncotarget; 2016 Jul; 7(30):47637-47649. PubMed ID: 27356745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.